Medical Biology: Containing excessively high medical expenses will become a major trend

Stocks with large gains in the previous period and lack of fundamental support face risk of correction. This week, the medical index rose by 2.55%, outperforming the Shanghai-Shenzhen 300 Index by 4.08 percentage points; including the Chinese Medicine Index (3.97%), chemical drug index (1.82%), biological medicine (1.42%), medical equipment (0.11%), and medicine Circulation (3.23%), medical services (-0.93%). In our weekly report last week, we pointed out that some of the stocks with large gains in the previous period and lack of fundamental support have high valuations and are facing the risk of callbacks. The individual stocks that rose earlier this month, such as Xinfu Pharmaceutical and Zixin Pharmaceutical, all saw a larger drop.

Guangdong Province Considers Requesting Major Hospitals to Use Essential Medicines and Curbing Rising Pharmaceutical Expenses Yao Zhibin, director of the Department of Health of Guangdong Province, revealed that this year he is considering asking major hospitals to use a certain percentage of essential drugs to curb rising drug costs. The essential medicines in our country were only used in basic medical institutions and have not been promoted to large hospitals. Because the structure of diseases in high-end hospitals is more complex, it is impossible to completely use basic medicines. The possible implementation method is to establish a certain proportion of base medicines for large hospitals. At present, many policies issued by the government departments are also focused on controlling the excessive rise in drug costs, to reduce the payment of temporary measures. Before the complete establishment of the public medical compensation mechanism, it is impossible for the hospital to completely eliminate the behavior of maintaining business or even profitability through excessive medical income. How to make the construction of the medical system in line with the residents' income growth and the continuous escalation of medical needs is a long-term process that needs continuous revision.

Beijing will select two top-three hospitals to separate pilot medicines and cancel the first work conference after the Beijing Hospital Authority will hold the bid on March 9. It is announced that in 2012, two third-tier A hospitals will be selected to pilot their medicines separately. Cancellation of medicine. The government will give full compensation to the pilot hospitals in seven areas including capital construction, purchase of large-scale equipment, and development of key disciplines. Medical workers' labor prices have been low in our country for a long time. We think that it is reasonable to increase service prices. The premise is that doctors no longer use “big prescriptions” and “high-priced drugs” to obtain income. This also requires the hospital to increase the income level of medical service personnel and change the status of “income generation” as a single assessment standard. On March 9th, the HA issued the “Management Measures for the Annual Performance Assessment of Municipal Hospitals of the Beijing Hospital Authority” to solicit public opinions. The dissatisfaction of the masses was considered as the most important criterion for evaluating hospital performance.

In December of Nanjing and Shenyang, the rankings of proprietary Chinese medicines were released this week to update the rankings of Chinese patent medicines for December in Nanjing and Shenyang. In Nanjing, we tracked 100 capsules of Huadong Medicine from No.5 in November to No.4. Kangyin Pharmaceutical's Noxious Injection fell from No.4 in November to No.7. Sales of Tanreqing Injection from Shanghai Kaibao in Shenyang region rose from the third in November to second, while Huaying Medicine's Bailing Capsule and Hongri Pharmaceutical's Xuebijing Injection were from November. The fifth and second places dropped to seventh and third places.